About ABBRATECH INC.
AbbraTech is a biotechnology company founded in 2020 in Branford, Connecticut, focused on antibody discovery using its proprietary EPIVOLVE platform technology to target disease proteins that are otherwise inaccessible with conventional methods.
Recombinant antibody discoverySite-specific antibody discoveryOvercoming low immunogenicityBypassing immune toleranceStructure-guided discoveryPhage display methodsImmunorepertoire analysisB cell cloning
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ABBRATECH INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.